These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1563212)

  • 1. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function.
    Portenoy RK; Thaler HT; Inturrisi CE; Friedlander-Klar H; Foley KM
    Clin Pharmacol Ther; 1992 Apr; 51(4):422-31. PubMed ID: 1563212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure.
    Portenoy RK; Foley KM; Stulman J; Khan E; Adelhardt J; Layman M; Cerbone DF; Inturrisi CE
    Pain; 1991 Oct; 47(1):13-19. PubMed ID: 1771088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers.
    Skarke C; Darimont J; Schmidt H; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2003 Jan; 73(1):107-21. PubMed ID: 12545149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain.
    Hoffman M; Xu JC; Smith C; Fanelli C; Pascal V; Degaetano C; Meenan G; Lehrer M; Lesser M; Citron M
    Cancer Invest; 1997; 15(6):542-7. PubMed ID: 9412659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers.
    Lötsch J; Stockmann A; Kobal G; Brune K; Waibel R; Schmidt N; Geisslinger G
    Clin Pharmacol Ther; 1996 Sep; 60(3):316-25. PubMed ID: 8841154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients.
    Sakurada T; Takada S; Eguchi H; Izumi K; Satoh N; Ueda S
    Pharm World Sci; 2010 Dec; 32(6):737-43. PubMed ID: 20730493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
    Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic nausea and morphine-6-glucuronide.
    Hagen NA; Foley KM; Cerbone DJ; Portenoy RK; Inturrisi CE
    J Pain Symptom Manage; 1991 Apr; 6(3):125-8. PubMed ID: 2016556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration.
    Peterson GM; Randall CT; Paterson J
    Eur J Clin Pharmacol; 1990; 38(2):121-4. PubMed ID: 2338107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.
    Schneider JJ; Ravenscroft PJ; Cavenagh JD; Brown AM; Bradley JP
    Br J Clin Pharmacol; 1992 Nov; 34(5):431-3. PubMed ID: 1467139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: modulatory role of testosterone via morphine clearance.
    South SM; Wright AW; Lau M; Mather LE; Smith MT
    J Pharmacol Exp Ther; 2001 Apr; 297(1):446-57. PubMed ID: 11259573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of hemorrhagic shock on the pharmacokinetics and the analgesic effect of morphine in the rat.
    De Paepe P; Belpaire FM; Rosseel MT; Buylaert WA
    Fundam Clin Pharmacol; 1998; 12(6):624-30. PubMed ID: 9818295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine glucuronidation increases its analgesic effect in guinea pigs.
    Oliveira A; Pinho D; Albino-Teixeira A; Medeiros R; Dinis-Oliveira RJ; Carvalho F
    Life Sci; 2014 Jul; 109(2):104-10. PubMed ID: 24968302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide.
    Osborne R; Joel S; Trew D; Slevin M
    Clin Pharmacol Ther; 1990 Jan; 47(1):12-9. PubMed ID: 2295214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients.
    Tiseo PJ; Thaler HT; Lapin J; Inturrisi CE; Portenoy RK; Foley KM
    Pain; 1995 Apr; 61(1):47-54. PubMed ID: 7644248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
    Faura CC; Moore RA; Horga JF; Hand CW; McQuay HJ
    J Pain Symptom Manage; 1996 Feb; 11(2):95-102. PubMed ID: 8907140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management.
    Smith MT; Wright AW; Williams BE; Stuart G; Cramond T
    Anesth Analg; 1999 Jan; 88(1):109-16. PubMed ID: 9895076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.